Cargando…

Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease

Induced pluripotent stem cell (iPSC)-derived dopaminergic (DA) neurons are an expected source for cell-based therapies for Parkinson’s disease (PD). The regulatory criteria for the clinical application of these therapies, however, have not been established. Here we show the results of our pre-clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doi, Daisuke, Magotani, Hiroaki, Kikuchi, Tetsuhiro, Ikeda, Megumi, Hiramatsu, Satoe, Yoshida, Kenji, Amano, Naoki, Nomura, Masaki, Umekage, Masafumi, Morizane, Asuka, Takahashi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338530/ https://www.ncbi.nlm.nih.gov/pubmed/32632153 http://dx.doi.org/10.1038/s41467-020-17165-w

Ejemplares similares

Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application
por: Hiramatsu, Satoe, et al.
Publicado: (2022)

Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation
por: Doi, Daisuke, et al.
Publicado: (2014)

Cell therapy for Parkinson’s disease with induced pluripotent stem cells
por: Morizane, Asuka
Publicado: (2023)

Zonisamide promotes survival of human‐induced pluripotent stem cell‐derived dopaminergic neurons in the striatum of female rats
por: Miyawaki, Yoshifumi, et al.
Publicado: (2020)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
por: Samata, Bumpei, et al.
Publicado: (2016)

Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson’s Disease Model
por: Adachi, Hiromasa, et al.
Publicado: (2022)

Panning for gold: Purifying mesencephalic dopaminergic progenitors differentiated from human pluripotent stem cells
por: Tang, Qingyuan, et al.
Publicado: (2022)

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
por: Kitano, Yuko, et al.
Publicado: (2022)

Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate
por: Morizane, Asuka, et al.
Publicado: (2013)

Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson’s disease: a systematic review protocol
por: Karimi, Aliasghar, et al.
Publicado: (2021)

Axonal Extensions along Corticospinal Tracts from Transplanted Human Cerebral Organoids
por: Kitahara, Takahiro, et al.
Publicado: (2020)

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
por: Fedele, Stefania, et al.
Publicado: (2017)

Rejuvenated Stem/Progenitor Cells for Cartilage Repair Using the Pluripotent Stem Cell Technology
por: Nakayama, Naoki, et al.
Publicado: (2021)

Directed Differentiation of Pluripotent Stem Cells into Kidney
por: Morizane, Ryuji, et al.
Publicado: (2015)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
por: Chlebanowska, Paula, et al.
Publicado: (2020)

Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
por: Kreutz, Anna, et al.
Publicado: (2023)

Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells
por: Kawamura, Fumihiko, et al.
Publicado: (2017)

A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
por: Nakagawa, Masato, et al.
Publicado: (2014)

Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson’s Disease Model Rats
por: Torikoshi, Sadaharu, et al.
Publicado: (2020)

Overview: an iPS cell stock at CiRA
por: Umekage, Masafumi, et al.
Publicado: (2019)

A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells
por: Hirai, Takamasa, et al.
Publicado: (2021)

MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells
por: Parr, Callum J. C., et al.
Publicado: (2016)

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
por: Grow, Douglas A., et al.
Publicado: (2016)

Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
por: Ohmine, Seiga, et al.
Publicado: (2011)

Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells
por: Yamashita, Tomoko, et al.
Publicado: (2017)

Cell Therapy for Parkinson’s Disease
por: MORIZANE, Asuka, et al.
Publicado: (2016)

Cryopreservation of Human Midbrain Dopaminergic Neural Progenitor Cells Poised for Neuronal Differentiation
por: Drummond, Nicola J., et al.
Publicado: (2020)

Analyzing mitochondrial respiration of human induced pluripotent stem cell-derived myeloid progenitors using Seahorse technology
por: Fan, Yanxin, et al.
Publicado: (2023)

Neural Progenitor Cells Derived from Human Embryonic Stem Cells as an Origin of Dopaminergic Neurons
por: Noisa, Parinya, et al.
Publicado: (2015)

Haematopoietic stem and progenitor cells from human pluripotent stem cells
por: Sugimura, Ryohichi, et al.
Publicado: (2017)

Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells
por: Guadix, Juan Antonio, et al.
Publicado: (2017)

Pluripotent stem cell model of Shwachman–Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors
por: Hamabata, Takayuki, et al.
Publicado: (2020)

Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage
por: Yang, Guang, et al.
Publicado: (2018)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential
por: Lange, Lucas, et al.
Publicado: (2020)

Inducible Forward Programming of Human Pluripotent Stem Cells to Hemato-endothelial Progenitor Cells with Hematopoietic Progenitor Potential
por: Lange, Lucas, et al.
Publicado: (2019)

Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease
por: Morizane, Asuka, et al.
Publicado: (2021)

A Comprehensive Analysis of Protocols for Deriving Dopaminergic Neurons from Human Pluripotent Stem Cells
por: Marton, Rebecca M., et al.
Publicado: (2018)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021)

Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson’s disease
por: Oosterveen, Tony, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8rrm96n4vnn4d7v2iepu8s9id